AI Optics

About AI Optics

AI Optics develops a handheld imaging device integrated with AI-based disease screening modules to provide accurate retinal diagnostics at the point of care. This technology addresses the barriers of access and cost associated with specialist assessments, enabling immediate and affordable screening for vision-related diseases.

```xml <problem> Access to specialist eye care is limited by the need for specialized equipment and trained personnel, resulting in delayed diagnoses and treatment for many patients. Barriers such as geographic location, lack of convenience, and high costs prevent patients from receiving timely retinal screenings. This leads to poor patient outcomes and increased disease progression. </problem> <solution> AI Optics has developed Sentinel, a handheld imaging device integrated with AI-based disease screening modules, to provide accurate retinal diagnostics at the point of care. The device combines high-performance imaging with AI algorithms to enable immediate and affordable screening for vision-related diseases. Its point-and-shoot capabilities and guided screening procedure facilitate seamless workflow integration. The technology aims to overcome barriers to specialist assessments, enabling widespread screening and early detection of retinal diseases. </solution> <features> - Portable, handheld form factor for point-of-care retinal imaging - Integrated AI-based disease screening modules for automated analysis - Clinically validated hardware and software with accuracy exceeding that of eye specialists - High processing speeds for instant in-person results - Guided screening procedure for ease of use - Low cost of goods sold (COGS) to ensure affordability </features> <target_audience> The primary target audience includes healthcare providers, particularly those in primary care settings, as well as vision clinics and screening programs seeking to improve access to retinal diagnostics. </target_audience> ```

What does AI Optics do?

AI Optics develops a handheld imaging device integrated with AI-based disease screening modules to provide accurate retinal diagnostics at the point of care. This technology addresses the barriers of access and cost associated with specialist assessments, enabling immediate and affordable screening for vision-related diseases.

Where is AI Optics located?

AI Optics is based in East New York, United States.

When was AI Optics founded?

AI Optics was founded in 2020.

How much funding has AI Optics raised?

AI Optics has raised 200000.

Location
East New York, United States
Founded
2020
Funding
200000
Employees
15 employees
Major Investors
Luminate

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI Optics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

AI Optics develops a handheld imaging device integrated with AI-based disease screening modules to provide accurate retinal diagnostics at the point of care. This technology addresses the barriers of access and cost associated with specialist assessments, enabling immediate and affordable screening for vision-related diseases.

aioptics.ai300+
cb
Crunchbase
Founded 2020East New York, United States

Funding

$

Estimated Funding

$100K+

Major Investors

Luminate

Team (15+)

No team information available.

Company Description

Problem

Access to specialist eye care is limited by the need for specialized equipment and trained personnel, resulting in delayed diagnoses and treatment for many patients. Barriers such as geographic location, lack of convenience, and high costs prevent patients from receiving timely retinal screenings. This leads to poor patient outcomes and increased disease progression.

Solution

AI Optics has developed Sentinel, a handheld imaging device integrated with AI-based disease screening modules, to provide accurate retinal diagnostics at the point of care. The device combines high-performance imaging with AI algorithms to enable immediate and affordable screening for vision-related diseases. Its point-and-shoot capabilities and guided screening procedure facilitate seamless workflow integration. The technology aims to overcome barriers to specialist assessments, enabling widespread screening and early detection of retinal diseases.

Features

Portable, handheld form factor for point-of-care retinal imaging

Integrated AI-based disease screening modules for automated analysis

Clinically validated hardware and software with accuracy exceeding that of eye specialists

High processing speeds for instant in-person results

Guided screening procedure for ease of use

Low cost of goods sold (COGS) to ensure affordability

Target Audience

The primary target audience includes healthcare providers, particularly those in primary care settings, as well as vision clinics and screening programs seeking to improve access to retinal diagnostics.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.